Physician profile
Abdo Bachoura
NPI 1578797676
$4,665.12
in general payments reported to CMS, 2019-2025
16 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,676 · 2020: $664 · 2021: $48.48 · 2022: $1,804 · 2023: $20.42 · 2024: $335 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,001.08 | 2019-2022 | |
| Integra Lifesciences Corporation | $586.93 | 2020-2022 | |
| Acumed LLC | $289.37 | 2019 | |
| Globus Medical, INC. | $162.03 | 2024 | Distal Radius Plate |
| Axogen | $148.98 | 2019-2020 | |
| Checkpoint Surgical, INC | $140.52 | 2024-2025 | Checkpoint Stimulators |
| Stryker Corporation | $61.43 | 2025 | Omega |
| Abbott Laboratories | $54.11 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $43.44 | 2022-2023 | Iovera, Zilretta, Exparel |
| Innovation Technologies INC | $40.71 | 2021-2025 | Irrisept |
| Averitas Pharma INC. | $28.71 | 2024 | Qutenza |
| Curonix LLC | $24.92 | 2022 | |
| Smith+Nephew, INC. | $24.49 | 2024 | Evos |
| Endo Pharmaceuticals INC. | $21.57 | 2022 | |
| Endo USA, INC. | $20.57 | 2025 | Xiaflex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Embody, INC. | $16.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdo Bachoura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.